Lupus Erythematosus Clinical Trial
Official title:
Psychosocial Consequences of Systemic Lupus Erythematosus: a Study of Patients and Their Spouses Psy-LUP Study
NCT number | NCT03913754 |
Other study ID # | 2018-29 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | June 30, 2019 |
Est. completion date | July 1, 2021 |
this project will allow us to evaluate and understand the impact of SLE on the couple's life and its relational and affective components. In addition, the Psy-LUP study will describe the representations that sick people and their relatives have of lupus disease. All the data collected will make it possible to target interventions with 1) patients and their relatives, in terms of therapeutic education, psychosocial support, support groups (associations); 2) caregivers caring for people with SLE, so that they can integrate the issues of the patient's experience in their care practice and their reflection on therapeutic strategies.
Status | Recruiting |
Enrollment | 160 |
Est. completion date | July 1, 2021 |
Est. primary completion date | July 1, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age> 18 years - Presenting an LES according to ACR or SLICC criteria - Being followed in Marseille in Nephrology or Internal Medicine as part of the Competence Center Lupus PACA - Having agreed to participate in the study after information Exclusion Criteria: - Minor person - Person deprived of liberty - Person not affiliated to a social security scheme |
Country | Name | City | State |
---|---|---|---|
France | Assitance Publique Hôpitaux de Marseille | Marseille |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique Hopitaux De Marseille |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the physical, psychological and social impact of chronic diseases | Quality of life scale Short Study Form-36 (SF-36) | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03543839 -
Trial of Belimumab in Early Lupus
|
Phase 4 | |
Terminated |
NCT02080195 -
Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)
|
Phase 1/Phase 2 | |
Completed |
NCT03098823 -
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE
|
Phase 4 | |
Recruiting |
NCT03562065 -
Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord
|
Phase 1/Phase 2 | |
Recruiting |
NCT05545839 -
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
|
N/A | |
Completed |
NCT05098600 -
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
|
||
Completed |
NCT04128579 -
Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
|
Phase 1 | |
Recruiting |
NCT06161363 -
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
|
||
Completed |
NCT03421184 -
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus
|
N/A | |
Not yet recruiting |
NCT02891213 -
Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.
|
N/A | |
Completed |
NCT01686555 -
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
Active, not recruiting |
NCT04018222 -
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
|
||
Completed |
NCT02747277 -
Analysis of B Cells From Autoimmune Individuals
|
||
Not yet recruiting |
NCT06426316 -
The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.
|
N/A | |
Recruiting |
NCT04213690 -
A Pilot Study to Explore the Role of Gut Flora in Lupus
|
||
Recruiting |
NCT06072287 -
The Living With a Long-Term Condition Study
|
||
Completed |
NCT02455089 -
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus
|
N/A | |
Completed |
NCT04089930 -
Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients
|
||
Completed |
NCT05945784 -
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
|
||
Completed |
NCT03253666 -
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
|